Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.

International journal of hematology

Volumn 94, Issue 4, 2011, Pages 355-360

  Yoshida, Kakunoshin ^a   Wada, Hideo ^b   Hasegawa, Masahiro ^b   Wakabayashi, Hiroki ^b   Ando, Honami ^b   Oshima, Seika ^b   Matsumoto, Takeshi ^b   Shimokariya, Yuji ^b   Noma, Katsura ^b   Yamada, Norikazu ^b   Uchida, Atsumasa ^b   Nobori, Tsutomu ^b   Sudo, Akihiro ^b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 10A; FONDAPARINUX; POLYSACCHARIDE;

AGED; ARTHROPLASTY; ARTICLE; BLOOD; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG ANTAGONISM; FEMALE; HUMAN; LUNG EMBOLISM; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PREMEDICATION; TREATMENT OUTCOME; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; BIOLOGICAL MARKERS; CHEMOPREVENTION; FACTOR XA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES; PREMEDICATION; PULMONARY EMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 85027937773     PISSN: None     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0933-5     Document Type: Article

References (0)